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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     
 
INTRODUCTION 
 
 
 Life expectancy is now increased and we are in the era of geriartric 
medicine. Geriartric gynaecological interventions are on the increase. New 
innovations  are coming up to  provide the best management option with 
minimum morbidity to this group of women. 
 
 Preventive medicine is gaining more importance and more women 
entering the climacteric, apart form facing psychological derangements, are 
scared by taboos about malignancies of the genital tract. 
 
1 in 20 women of 40-49 years, consult their gynaecologist with 
history of excessive bleeding per vaginum atleast once in their life time. 
 
1 in 5 women in UK are undergoing hysterectomy before 60 years.Out 
of them, 50 percent women undergo hysterectomy for menorrhagia. 
 
In 50 % of hysterectomies, the uterus removed has no local 
pathology.Uterus is just the target organ responding to the variations in 
Hypothalamo pituitary ovarian axis. 
 
        But before we conclude the uterus to be a  mere innocent target organ, 
there should be conclusive evidence. A step towards  such a conclusion 
should be  cost effective, easily available and safe. 
 
 The idea of fractional curettage  for all patients with perimenopausal 
and post menopausal abnormal uterine bleeding is now shifting towards 
hysteroscopy guided biopsy. Such sophisticated investigations demand 
greater technical skill and expertise which most patients cannot reach. 
 
 Mere sonography can miss early malignancies & polyps. A simple 
modification of saline infusion sonohysterography [SIS],has become a handy 
tool, an alternative to hysteroscopy in the evaluation of abnormal uterine 
bleeding. 
 
 SIS can rule out malignancy with 100% sensitivity.  But to confirm 
malignancy, further biopsy  and HPE are mandatory. 
 
 The combination of sonohysterography & endometrial biopsy offers 
high sensitivity & negative predictive values for detection of endometrial & 
uterine pathology in patients with abnormal bleeding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF STUDY 
 
 
 
 
 
 
 
 
 
 
 
AIM OF STUDY 
 
 
 To evaluate the efficacy of saline infusion sonohysterography in the 
investigation of abnormal uterine bleeding in perimenopausal and post 
menopausal women. 
 
 To correlate the findings of saline infusion sonohysterography with 
histopathology of endometrium  by fractional curettage and 
hysterectomy specimens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS  
STUDY DESIGN                         - prospective descriptive clinical Trial 
TYPE OF ANALYSIS                  -     qualitative analysis  
NATURE OF STUDY               - prospective cohort study  
POPULATION UNDER STUDY -      perimenopausal, post menopausal     
women attending gynaecological 
OPD in Govt. Rajaji hospital, 
Madurai 
STUDY SAMPLE    -    50 women  in perimenopausal  &  
post menopausal age group with 
complaints of  abnormal uterine 
bleeding 
 
INCLUSION CRITERIA              -  age 40-55 yrs   
EXCLUSION CRITERIA 
1. Unwilling patients  
2. Suspected pelvic infection 
3. profusely  bleeding  patients requiring therapeutic curettage. 
4. premalignant/ malignant lesions of cervix 
5. large myomas 
6. cervical stenosis 
 
 
METHODOLOGY 
 
After detailed  history, medical & gynaecological examination done. 
Verbal consent obtained. 
Procedure is done on day 6 or 7 in patients with regular cycles or just 
after cessation of  bleeding in those with irregular cycles. 
All patients were subjected to standard TVS with empty bladder. 
The TVS probe was removed &  SIMS speculum was inserted to 
visualise the cervix , and the anterior lip was held with a volsellum 
Cervix was cleaned with povidone iodine, 8  size infant feeding tube 
was slowly introduced into the uterine cavity 
The probe was reintroduced into the vagina with the tube in situ . 
Sterile saline about 10 ml was slowly injected through the tube & cavity 
distended. 
The uterus was scanned in  longitudinal axis from one corner to other, 
then in transverse direction from fundus to cervix. 
Those who complained of abdominal pain were given a single tablet 
mephenamic acid 500 mg. 
All 50 patients were subjected to fractional curettage  in the 
premenstrual phase & Histopathologic examination of endometrium done. 
Correlation between  SIS findings   and HPE studied. 
35 patients underwent hysterectomy for various reasons like 
adenomyosis, fibroid uterus,endometrial hyperplasia,endometrial polyps. 
Correlation between SIS findings and cavities of uterine specimens studied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
  
 
 
 
 
 
The most probable etiology of abnormal uterine bleeding and the 
likelihood of serious endometrial pathology relates to  the patients  age . 
 
 In perimenopausal and postmenopausal  patients especially in those 
with high risk factors like obesity, hypertension, diabetes, patients on 
HRT,etc, endometrial  carcinoma has to be ruled out. 
 
 Presence of pathological lesions like polyps, fibroids, endometrial 
hyperplasia has to  be identified before planning appropriate modality of 
management.In patients who by exclusion, have been diagnosed as having 
dysfunctional uterine bleeding hormone therapy makes it possible to avoid 
surgical interventions. 
 
ANATOMY AND HISTOLOGY OF NORMAL 
ENDOMETRIUM  
 
 Endometrium is the specialized form of membrane lining the uterine 
cavity. 
 
 It is formed by a single layer of cuboidal or columnar epithelium 
which dips in to form tubular glands. 
 
 Stroma is made of loosely  arranged connective tissue cells, blood 
vessels, lymphatics and leucocytes. 
  Endometrium shows cyclic histological and functional changes in 
relation to various phases of menstrual cycle. 
Functionally divided into 2 zones  
 
1. Functional layer-forms  superficial 2/3 of the endometrium.This is the 
cyclical portion that responds to hormonal changes of normal 
ovulatory cycle. Has two layers, stratum compactum and stratum 
spongiosum.  
 
2. basal layer – deep portion  forming remaining 1/3 of the endometrium, 
not cyclical, contributes to regeneration.It does not respond to 
hormonal stimulation. 
 
 
ENDOMETRIAL CYCLE  
 
Described  in detail by  Noyes, Hertig & Rock in 1950. 
FOLLICULAR PHASE 
At the end of menstruation- endometrium measures 1mm, glands are 
broken, only basal layer remains . 
         Regrowth commences even in the absence of hormonal stimulation 
on the third or fourth day evidenced by healing of the surface epithelium. 
 Between fifth and fourteenth day of a regular 28 day cycle there is 
synchronous stromal, vascular and glandular growth. 
       In the early part of the proliferative phase, the glands are straight and 
tubular. 
 
 
In the later part of the proliferative phase,glands become progressively 
convoluted and stromal edema appears.Late proliferative phase . 
Endometrium measures 2-3mm at the end of this phase.  
 
SECRETORY PHASE –14 to 28th day , secretory changes and  
This is characterized by stromal maturation and glandular secretion in 
response to progesterone produced by corpus luteum. 
The first presumptive evidence of ovulation is the appearance of 
subnuclear vacuoles in glandular epithelium. 
During mid secretory phase,the secretion of glandular epithelial 
contents occur. 
Stromal edema reaches a peak on day 22 or 23. 
Spiral artery differentiates and predecidual cells become apparent on 
day 23. 
During the late secretory phase there is exhaustion of glandular 
secretory activity.The glands become tortuous and there is reduction in 
endometrial height due to regression of stroma. 
Endometrium measures 8-10 mm. at the end of this phase. 
 
Just before menstruation- decreased blood flow &infiltration with 
leucocytes occur.Over the next 24 hours ,a plane of separation becomes 
apparent through the spongy layer,which leads to the separation of 
superficial endometrium from the basalis. 
  
HPOU AXIS & HORMONAL CYCLE  
 
FSH Æ follicle maturation & estrogen production . Estrogen has 
postive feedback on LHÆ LH surge & ovulation , corpus luteum synthesises 
progesterone which produces secretory changes in estrogen  primed 
endometrium in the luteal phase. 
 
PATHOLOGICAL LESIONS CAUSING ABNORMAL 
UTERINE BLEEDING 
 
1.Endometrial hyperplasia  
 
Endometrial hyperplasia represents a spectrum of biological & 
morphological alteration of endometrial  glands ranging  from  exaggerated 
physiological state to carcinoma in situ. 
 
The most  recent classification by the International society of 
gynaecological  pathologists  is based  on both architectural  and cytological 
features and long term studies that reflect natural history of the lesion21 
 
 
 
 
 
 
 
 
 
Types of hyperplasia 
 
Sl.No Typical  progression  to 
carcinoma 
1 Simple hyperplasia (cystic glandular) 1% 
2 Complex hyperplasia (adenomatous) 3% 
 Atypical  
1 Simple hyperplasia  8% 
2 Complex hyperplasia 29% 
                                                                                  [Novak et al.] 
 
1. Simple (cystic glandular) – characterized by dilated or cystic glands 
with round to slightly irregular shape; increased glandular  to stromal 
ratio with out glandular crowding and no cytologic atypia. 
2. Complex (adenomatous hyperplasia) –  increased  no of glands, 
closely packed with little intervening stroma, multilayering of 
epithelium  with budding  and infolding. 
3. Atypical hyperplasia – Both simple  and  complex  hyperplasia can be 
associated with cytologic atypia. The nuclei are unusually large , 
pleomorphic, hyperchromatic.There is increased nuclear cytoplasmic 
ratios & prominent  nucleoli with irregular clumping of chromatin and 
parachromatic clearing. 
 
Most of the hyperplasia seem to remain stable (18%) or regress (74%) 
                                                                           – (kumar RJ etal 1985).  
Premalignant  potential of  hyperplasia is influenced  by  the following  
factors .  
1. Age of patient 
2. Underlying ovarian disease  
3. Endocrinopathies  
4. Obesity  
5. Exposure to exogenous estrogens ( Hunter J E et al 1994)  
 
2 Atrophic endometrium- postmenopausal 
There is no functionalis layer and uterus is lined only by basalis layer. 
Stroma becomes fibrous and stromal cellularity diminishes. This is 
called senile cystic  atrophy. 
 
3.Endometrial  Carcinoma  
Grossly, endometrial carcinoma presents as either localized 
polypoidal tumor  or as a diffuse  tumour involving the endometrial 
surface. Histologically 80 % are adenocarcinoma , characterized by 
more or less well defined  glandular patterns  lined by malignant 
stratified  columnar epithelial cells. 
 
Histological classification 
1. Adeno carcinoma  - Usual type      
  Variants - Villoglandular  
                -   Secretory 
                          -   With squamous differentiation 
2.   Mucinous carcinoma 
3.   Papillary serous carcinoma 
4 Clear cell carcinoma 
4. squamous cell carcinoma 
5. undifferentiated carcinoma 
6. mixed carcinoma  
 
4.Endometrial polyps 
A mucous polyp otherwise called true adenoma occurs with or 
without associated endometrial hyperplasia.polyps can be single or 
multiple.The tumour is usually the size of a grape and is not larger 
than a pea.On section it shows endometrial glands and stroma.These 
may or may not respond to ovarian hormones.The cause  of single 
mucous polyp is unknown. 
                 Single endometrial polyps are common in the post 
menopausal uterus when they are mostly symptomless.Symptoms are  
more likely when the tip of the polyp becomes necrotic and 
ulcerated.Symptoms are usually bleeding pv,discharge pv or 
abdominal colic . 
                    Multiple polyps are generally a manifestation of endometrial 
hyperplasia with persisting background of hyperestrogenism. 
                    
•  Benign -  Adenoma 
-  leiomyoma 
- Placental 
       •  Malignant 
- carcinoma 
- sarcoma 
- choriocarcinoma 
 
5.Leiomyoma-  
 
Especially intramural and submucous  fibroids cause abnormal uterine 
bleeding due to  
 increase in endometrial surface area >200 cm sq. 
 Associated endometrial hyperplasia. 
 interference with normal myometrial contractility. 
 endometrial venule ectasia and increased  vascularity. 
 infection & ulceration of submucous fibroid . 
 
6.Other differential diagnosis for Abnormal uterine bleeding 
1. Infection  -   cervicitis  
- endometritis  
- PID 
2.Ovarian/ cervical malignancy 
3.Adenomyosis 
 4. Systemic diseases – hepatic, renal disease, coagulopathy, leukemia 
6. Drugs / Iatrogenic – IUCD , OCP 
7. Endocrinological causes- Hypothyroidism, Hyperprolactinemia, 
Cushings disease, abnormality in HPOaxis, anovulatory cycles. 
 
 
 
 
 
 INVESTIGATIONS  IN ABNORMAL UTERINE BLEEDING 
1.DILATATON & CURETTAGE 
 
Initially, D & C was the diagnostic procedure used to identify the 
histology of the endometrium in the evaluation of Abnormal uterine 
bleeding. 
Recaimer invented the curet in 1943. 
In 1958 total of 6907 D&C were reviewed and the concept was that  
curettage was simple and harmless, easy to perform even by  the  
internist(word b et al) .It is therapeutic in 30% cases of  Dysfunctional 
uterine bleeding.  
Disadvantages 
 Hospitalisation 
 Risk of anesthesia  
 Risk of perforation 
 Risk of  sepsis  
 Bleeding  
 Frequently misses uterine polyps  
 Cannot diagnose submucous myoma 
 Samples only 60% of endometrial surface. 
 
2.OFFICE  ENDOMETRIAL  BIOPSY 
 
 In 1924, it was recommended that a diagnostic biopsy  of the 
endometrium could be performed with out anesthesia.(Kelly h A 1925) 
 Using  Novak Curette/ newer silastic curette or pipette suction curette 
, it can be  done as an outpatient procedure requiring  no anesthesia as these 
tools need no  cervical dilatation. 
 
 Suction curette is 98% accurate in evaluating high risk women with 
abnormal  bleeding  for endometrial  malignant disease.(Lutz Mn et al 1977) 
 
Disadvantages  
• not sensitive for detection of structural abnormalities   
• polyps & fibroids cannot be  diagnosed 
• samples only 5% of endometrial  surface. 
• risk of uterine perforation 
• pain  & cramping  during endometrial sampling  
• vasovagal reaction can  rarely occur.  
• bleeding  
• infection  
  In cervical  stenosis- performance of biopsy is difficult 
 
3.HYSTEROSALPINGOGRAPHY 
 Not a suited mode of investigation in abnormal uterine bleeding  
 Risk of radiation 
 Iodine allergy may occur  
 Myometrial abnormalities/ adnexal disorders cannot be diagnosed  
 Polyps cannot be  differentiated  from sub mucous myomas. 
 Complications like pain, intravasation of dye and granuloma  
formation may occur. 
4.HYSTEROSCOPY 
                It is possible to visualize the cavity of the uterus with 
hysteroscopes incorporating fibre-optics.Hysteroscopy is used to exclude 
intra uterine pathology as a cause of abnormal bleeding. 
Hysterscopic procedures were first described by Pantaleoni in 1869. 
 It  is the  gold standard procedure of investigation in Abnormal uterine 
bleeding, because it enables selective biopsy of the areas  of visualized 
endometrium that appear neoplastic and also facilitates diagnosis of polyps,  
sub mucous myomas, intra uterine adhesions etc. 
 
Hysteroscopic operations in selected cases  can also prove 
therapeutic.It offers opportunity for removal of polyps .Intra uterine 
synechiae can be divided .Endometrial ablation procedures can also be done 
with hysteroscopy. 
 
  The procedure involves dilatation of the cervix followed by 
introduction of the hysteroscope.It has a side channel which permits the 
passage of the distension medium.For operative hysteroscopy,an additional 
channel permits the introduction of the resectoscope,roller ball or laser 
fibre.An outflow tract allows the fluid passing out to be collected in a bottle. 
 
  Special collecting bags have been deviced which are placed under 
the patient’s buttocks to collect any fluid leaking out of the vagina to allow 
an accurate estimation of the fluid deficit and prevent fluid overload. 
 
      Office hysteroscopy using new smaller diameter flexible or rigid 
hysteroscopes is coming up.This diagnostic procedure is done under local 
anesthesia using a hysteroscope of smaller diameter less than 4 mm so that 
cervical dilatation is not required. 
 
Disadvantages 
 Cannot form first line of investigation in Abnormal uterine bleeding. 
 Myometrial / adnexal abnormalities cannot be  identified  
 Expenditure  
 Invasive  
 Requires anesthesia for proper evaluation 
 Can be done only in operation theatre set up 
 Requires  special expertise to handle the instrument  
 Needs technical skill and knowledge to interpret 
 Risk of intraoperative and postoperative  bleeding  
 Fluid retention  
 Uterine  perforation  
 Gas embolism 
 Infection 
 Poor visibility if  done with bleeding pv  
 
5. TRANSVAGINAL SONOGRAPHY 
 
Transvaginal sonography has been investigated as a screening tool in  
peri and post menopausal patients with Abnormal uterine bleeding. 
The first report of TVS is attributed to kratochwil in 1969.The transvaginal 
sonography probe generates waves of a higher frequency,5.5 to 7.5MHz. 
 
 The use of transvaginal approach for imaging endometrium , 
myometrium and ovaries  is superior to TAS because of the close proximity 
of the probe to uterus and adnexa. 
 
 Measurement of endometrial thickness includes the 2 layers – 
anterior& posterior wall at the thickest portion in the mid saggital plane. If 
the endometrial thickness is less than 5mm , the pathology would show 
either inactive or no endometrial tissue.(Nasri MN 1991) Post menopausal 
patients with endometrial echo of  more than 4mm had sensitivity of 96% 
specificity 0f 68% for selecting endometrial pathology.(gell B,Karlsson B et 
al 2000) 
 
 
6.SALINE INFUSION SONOHYSTEROGRAPHY 
 
 Sonographic evaluation of endometrium can be enhanced by 
instillation of sterile saline into the endometrial  cavity as observed during 
transvaginal  sonography. It is of particular use in assessment of patients 
with thickened endometrium on sonography, in patients with scanty tissue 
on D&C and also to identify location & extent of intra uterine synechiae or 
septa or polyps- Dodson et al. 
 
 “Fluid is sonologist’s  friend”. This is known from the enhanced 
sonographic visualization we observe with polyhydramnios, fluid in the 
dominant follicle , 2nd trimester ultrasound. This concept led to the discovery 
of SIS. 
          The introduction of saline into the uterine cavity provides a contrast 
that helps localization of abnormalities as intracavitary,endometrial or 
submucousal.Fluid represents an excellent medium for transmission of 
sound waves and provides a good contrast to examine the endometrial 
cavity. 
         The saline also distends the endometrial cavity separating endometrial 
walls so as to visualize polyp that could be seen as the part of overall 
endometrial thickness, when both walls are measured together in the 
standard scan. 
 In 108 patients with Abnormal uterine bleeding it  had an overall 
sensitivity comparable to the gold standard of hysteroscopy  & better than 
either MRI or TVS 
 
 Dr Goldstein is the inventor of the Goldstein sonohysterography 
catheter and the principal investigator and teacher of the technique . In a 
recent study of 400 women with abnormal bleeding, 19% had no anatomic 
abnormality and needed no further diagnostic procedure other than 
SIS.(Goldstein SR 1996) 
 
 
ADVANTAGES OF SIS  
 
 ACCURACY 
It definitely enhances the diagnostic potential of TVS in assessment of 
endometrium and intracavitary pathologies.(Bart Kowial R,Kaminski 2003) 
Sonohysterography allows a precise diagnosis of benign uterine 
pathology which generally basal transvaginal ultrasonography can only 
suspect. The conclusion drawn is that this new method offers an important 
aid for gynaelogical diagnosis of benign pathology.(Dodero D,Corticelli A 
2001) 
 
With out  SIS  the diagnosis of focal lesions  such as polyps, 
submucous myomas & focal hyperplasia would have been missed .(Jones 
K,Bournet 2001) 
 
 Easy to use  
most authors encountered no failures(cullinan JA,Heischer AC 1995) 
 Cost effectiveness 
Apart from catheter, syringes, saline, the technique does not  have 
additional requirements other than those  needed for  standard 
TVS(Epstein E,laife-Narin Sl 1999) 
 Minimally invasive  
 Needs no anesthesia 
 Needs no prior cervical dilatation 
 Provides excellent visualization of endometrial cavity  
 Can  differentiate polyps & sub mucous myoma 
 Intramural and adnexal pathology can be simultaneously studied  
 Unlike TVS,SIS can detect focal hyperplasia .Endometrial thickness 
of each wall is measured separately identifying focal thickening(bron 
Z,L sulter T,Russia 1997) 
 No risk of ionizing radiation  
 No risk of perforation  
INDICATIONS OF  SONOHYSTEROGRAPHY  
 
     1. Abnormal uterine bleeding in peri and post menopausal women. 
                Evaluation of abnormal uterine bleeding necessitates 
excluding local causes especially in peri and post menopausal 
patients.(Weeks AD, Duffy SRG 1996) 
2. Evaluation of  endometrium that is  thickened irregular or poorly 
visualized  in conventional TVS 
3. Follow up of women receiving HRT  
               4. Follow up of women receiving tamoxifien 
     5. Follow up in cases of conservative management of endometrial 
         hyperplasia  
               6. Presurgical evaluation of intracavitary fibroids  
    7. Infertility & recurrent pregnancy loss 
                         Saline hysterography in these patients is a reliable  
alternative  that can avoid hysteroscopy  in those patients with out a septum 
& guides resection in those with septate uterus(Clifford K,Regan L 1994) 
 
8. Secondary amenorrhea – due to Asherman’s syndrome, SIS can 
avoid the use of  hysteroscopy in those without such adhesions and 
guide resection in those with adhesions.(Asherman 1948, pinion 
1944) 
 
9. Assisted  reproductive technology- patients undergoing ART are 
often investigated for abnormalities of uterine cavity such as  fibroid  
ployps & uterine septae which need resection to avoid failure of 
implantation.(Ayida G,Chamberlain B 1997) 
  
NORMAL FINDINGS OF SIS  
 
 The procedure is best done in proliferative phase when the 
endometrium is thin to facilitate detection of polyps.(Lindheim SR,Morales 
AJ 2002) 
 
1. Normal endometrial cavity should distend  symmetrically, is well 
demarcated and surrounded by anechoic saline. 
2. Homogenous single layer thickness of endometrial lining in relation to 
phase of menstrual cycle.  
3. Fluid in culdesac – indicating patent fallopian tubes.(Laifer-Narin SL 
1999) 
 
ABNORMAL  FINDINGS IN SIS  
 
1. Endometrial polyps appear as protrusions into the cavity and  move 
characteristically upon injecting  saline.(Lasek W,Migda M 
2004)This movement differentiates the polyps from blood clots 
which can be displaced anywhere in the cavity. 
 
2. Intracavitary & sub mucous fibroids – appear as filling defects  
with mixed echogenicity that is different to the endometrium with 
which they are usually covered.(Baldwin MT,Dudiak KM 
1999)Extension of fibroids upto serosal surface of uterus has to be 
noted as resection of fibroids should not be attempted in these 
cases. 
 
 
3. Focal endometrial thickening  
Endometrial thickness of each wall  is measured separately 
identifying  focal thickening.(Bron Z LSubtert 1997)This will later 
guide biopsy at hysteroscopy. 
 
Irregularity in the surface of endometrium,heterogenecity of 
the endometrium,irregularity of the junction between the 
endometrium and the myometrium and uniform increased 
echogenecity of the endometrium all raise the suspicion of 
malignancy. 
 
4. Abnormalities of uterine cavity 
 Intrauterine adhesions and malformations of uterine cavity 
appear as immobile  connections between the  uterine 
wall.(Parsons AK,Lanv 2 1993)If adhesions are thick and wide 
spread,distension of the cavity will be difficult. 
 
          Incomplete separation of the anterior and posterior uterine 
walls,in longitudinal sections of the uterus denotes intrauterine 
synechiae and can give the uterus a bow tie appearance on transverse 
sections. 
 
 
           Malformations of the uterine cavity could cause much thicker 
connections between the anterior and  posterior walls. 
5. endometrial atrophy  
  
LIMITATIONS  
 
1. Pregnancy  has to be ruled out before the procedure. 
2. PID–As with all forms of uterine instrumentation,this test should 
only be performed after pelvic infection has been excluded.Patients 
with history of chronic pelvic infection are given a course of the 
Doxycycline.(Linheim SR,Morales A5 2002) 
3.  In submucous fibroids obliterating cavity larger than 4 cm the 
cavity cannot be adequately distended  
4. cervical stenosis can be managed by  dilating the cervix under 
local anesthesia.(Wilrich J,Bradley Ld 1996) 
5. Extensive  intrauterine synechiae  may limit feasibility  of the 
procedure 
6. Patients  may develop  occasionally  uterine  cramps that can be 
avoided by oral antispasmodics before the procedure.(Bonnamy 
L,Marret H,2002) 
 
COLOUR DOPPLER IMAGING  
 Colour Doppler and blood flow analysis in combination with SIS is 
generally promising  in identifying  patients with endometrial carcinoma and 
differentiating between  benign & malignant uterine tumors .Malignant 
tumours have neovascularisation and angiogenesis. 
COMPUTERISED TOMOGRAPHY  
           Computerised Tomography with contrast enhancement enables the 
pelvic organs to be delineated clearly.  
It is used for staging  endometrial carcinoma  with accuracy of 84% to 
88%.  
CT is a useful non invasive test to differentiate disease  confined to 
uterus from extrauterine pelvic and abdominal spread.  
Lymph node involvement is well demonstrated.But its role as a 
screening procedure is not appealing. 
 
MAGNETIC RESONANCE IMAGING  
  This is the latest addition to the diagnostis modalities but it is still not 
available in most parts of the developing world. 
 
Is the study of choice for  accurate staging of endometrial  
carcinoma.Abnormalities can be detected in about 84% of patients with 
endometrial carcinoma.MR is advantageous over CT because of no 
radiation exposure ,imaging is mutiplanar,no contrast is required ,soft 
tissue resolution is superior to CT.But it is expensive. 
 
 
 
 
 
 
 
 
35 patients underwent hysterectomy for various reasons like 
adenomyosis, fibroid uterus,endometrial hyperplasia,endometrial polyps. 
Correlation between SIS findings and cavities of uterine specimens studied. 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS  
    
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGE DISTRIBUTION 
 
TABLE 1 
 
S.No Age in years  No. of patients  Percentage  
1 40-45  24 48 
2 46-50  20 40 
3 51-55 6 12 
 
 
 88% of patients taken up for study belonged to 40-50 yrs. Only 12% 
were in the age group of 51-55 yrs . 
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PARITY DISTRIBUTION 
TABLE 2 
 
S.No Parity No. of patients  Percentage  
1 P0 1 2 
2 P1 3 6 
3 P2 15 30 
4 P3 15 30 
5 P4 8 16 
6 P5 5 10 
7 P6 1 2 
8 P7 2 4 
  
 60% patients belonged to para2 & para3 .Only 2% was  nullipara. 
 32 % patients were para4 and above.  
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SOCIO ECONOMIC STATUS 
TABLE 3 
 
Class No. of patients  Percentage 
III 5 10 
IV 5 10 
V 40 80 
 
 
80% patients were belonging to low socio economic status.  
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DISTRIBUTION OF PERI AND POST MENOPAUSAL 
ABNORMAL UTERINE BLEEDING 
TABLE 4 
 
S.No Type of AUB No. of patients  Percentage  
1 Perimenopausal 41 82 
2 Postmenopausal 9 18 
 
 82% of patients included in the study had perimenopausal abnormal 
uterine bleeding .18% were postmenopausal patients. 
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CLINICAL PRESENTATION OF PERIMENOPAUSAL AUB 
TABLE 5  
 
S.No Clinical 
presentation 
No. of patients  Percentage  
1 Menorrhagia 19 46.34 
2 Polymenorrhea 4 9.75 
3 Polymenorrhagia 12 29.26 
4 Menometrorrhagia 6 14.63 
 
 Almost 75% patients had either polymenorrhagia or menorrhagia. 
Nearly 10% had polymenorrhea & 14.6% had menometrorrhagia 
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DURATION OF SYMPTOMS – PERIMENOPAUSAL                            
TABLE 6  
  
S.No Duration No. of patients  Percentage  
1 < 5 months 6 14.63 
2 6-12 months 25 60.97 
3 13-24 months 8 19.51 
4 > 2 years  2 4.87 
 
                    Nearly 75 % percent patients reported to the hospital with in 1 
year of onset of symptoms. Only 4.8% reported late after 2 years and about 
20 % reported with in 1-2 yrs.  
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DURATION OF SYMPTOMS IN POSTMENOPAUSAL 
           PATIENTS 
 
TABLE -7 
 
S.No Duration  No. of patients  Percentage  
1 <10 days  5 55.55 
2 11-30 days 2 22.22 
3 2-4 months 1 11.11 
6 4-6 months 1 11.11 
 
 Nearly 77% patients reported with in 1 month of symptom onset. Only 
about 22% reported late with in 6 months.Only one patient has 
adenocarcinoma endometrium.She had bleeding per vaginum for 6 months. 
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ASSOCIATED MEDICAL CONDITIONS 
TABLE -8 
 
S.No Medical disorders  No. of patients  Percentage  
1 Diabetes mellitus  7 14 
2 Hypertension 11 22 
3 Obesity/overwt BMI>25 13 26 
4 Anemia 12 24 
 
 14 % patients  were diabetic, 22% had hypertension.26% had BMI 
>25.  6% were both  hypertensive & diabetic.24%of patients were severely 
anemic requiring blood transfusions.  
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 CLINICAL DIAGNOSIS 
TABLE- 9 
 
S.No Clinical findings No. of patients  Percentage  
1 Cervical polyp 3 6 
2 Adnexal mass 3 6 
3 Fibroid  5 10 
4 DUB 39 78 
 
 On clinical examination,3(6%) patients had cervical polyp.Out of 
which 2(4%)were mucous polypi and 1(2%) was a myomatous polyp.All 
three underwent polypectomy.Out of 3 (6%)adnexal masses,1(2%) turned 
out to be hydrosalpinx,2(4%) were functional cysts of ovary.39(78%) 
patients were clinically diagnosed as dysfunctional uterine bleeding. 
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ASSOCIATED FINDINGS BOTH IN TVS & SIS 
TABLE 10 
 
S.No Findings No. of patients  Percentage  
1 Fibroid  10 20 
2 Adenomyosis 7 14 
3 Hydrosalpinx 1 2 
4 Ovarian Cyst 2 4 
 
TVS and SIS showed that associated fibroids were present in 10(20%) 
patients. 
  7(14%) patients had Adenomyosis. Hydrosalpinx was present in 1(2%) 
patient  and ovarian cyst in 2(4%) patients ,both were functional cysts. 
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ENDOMETRIAL THICKNESS IN SIS 
TABLE  11 
 
 
S.No Thickness  No. of patients  Percentage  
1 0-5 15 30 
2 6-10 20 40 
3 11-15 6 12 
4 16-20 7 14 
5 >20 2 4 
 
 Endometrial  thickness is the sum of thickness of anterior & posterior 
endometrium  at the thickest portion after distension of cavity. It was  
uniformly equal in 46(92%) patients except  in 4(8%) who had focal 
thickening of endometrium  in one wall.Thickness >5 mm is considered 
hyperplasia in the post menstrual phase.35(70%) patients had hyperplasia 
according to SIS. 
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FINDINGS  DIAGNOSED ONLY BY SIS 
TABLE 12 
 
S.No Age in years  No. of patients  Percentage  
1 Endometrial polyp 4 8 
2 Submucous fibroid 4 8 
3 Generalised thickened 
endometrium 
31 62 
4 Focal  thickening of 
endometrium 
4 8 
5 Intramural fibroids distorting 
cavity 
5 10 
6 Suspected malignancy- polyp 1 2 
7 Suspected malignancy-focalH  1 2 
 
  
Fibroids were present in 11 (22% ).3(6% ) patients with submucous  fibroids 
had associated intramural fibroid.Out of 4(8%)polyps  identified, 2(4%) 
turned out to be adenomatous polypi, 1(2%) was a myomatous polyp with a 
pedicle .1(2%) patient  with irregular polypoidal projections into the cavity 
had adenocarcinoma endometrium. 
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HPE OF  ENDOMETRIUM BY FRACTIONAL 
CURETTAGE  
TABLE 13 
 
S.No Type of endometrium No. of patients  Percentage  
1 Atrophic 6 12 
2 Proliferative 18 36 
3 Secretory 13 26 
4 Cystoglandular Hyperplasia 10 20 
5 Simple Adenomatous 
hyperplasia 
1 2 
6 Atypical adenomatous 
hyperplasia 
1 2 
7 Adenocarcinoma 1 2 
 
                 5(10%) patients had atrophic endometrium, 18 
(36%)patients had proliferative endometrium,13 (26%)had 
secretory endometrium.Endometrial hyperplasia was seen in 
12(24%) patients,out of which 10(20%) had cystoglandular 
hyperplasia,1(2%) simple adenomatous 
hyperplasia,1(2%)atypical adenomatous 
hyperplasia.Adenocarcinoma was seen in 1(2%) patient. 
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CORRELATION BETWEEN SIS & HPE 
TABLE 14 
 
S.NO Thickness 
mm 
Atrophic  Proliferative Secretory CGH SAH AAH CA 
1 A (0-5) 6(40%) 7(46.66%) 2(13.33%) - - - - 
2 B( 6-10) - 5(25%) 11(55%) 4(20%) - - - 
3 C (11-15) - 2(33.33%) - 3(50%)  1(16.66%) - - 
4 D(16-20) - 3(42.85%) - 3(42.85%) - - 1(14.28%)
5 E >20 - 1(50%) - - - 1(50%) - 
 
 
 
 
 Out of 31(62%)cases with globally thickened endometrium  ,32.25% 
had proliferation, 35.48%  had secretory endometrium, 29.03% had 
cystoglandular hyperplasia and 3.22% had simple adenomatous hyperplasia..  
Out of 4(8%) focal hyperplacia,atypical adenomatous hyperplacia,disorderly 
proliferative endometrium,cystoglandular hyperplasia,adenomocarcinoma 
were equally distributed 1(25%) patient each. 
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HYSTERECTOMY SPECIMENS- CAVITY 
TABLE 15 
 
S.No Cavity No. of patients  Percentage  
1 Normal  21 60 
2 Polyps 3 8.57 
3 Submucous fibroid  3 8.57 
4 Intramural fibroid  6 17.14 
5 Carcinoma  1 2.85 
6 Others -  lippes loop 1 2.85 
  
Out of 50 cases, 35(70%)underwent hysterectomy for fibroid, 
adenomyosis, endometrial hyperplasia, endometrial  polyps and   carcinoma 
endometrium  
 
21 (60%)patients had normal cavity on cut section. 3(8.57%) polyps 
were identified, 3(8.57%) submucous fibroids , 6 (17%)specimens showed 
distortion of cavity by intramural fibroids, 1 (2.85%)had  lippes 
loop,1(2.85%) showed features of   carcinoma endometrium    friable 
proliferative growthwith necrosis filling the cavity. 
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CORRELATION BETWEEN SIS AND HYSTERECTOMY 
SPECIMENS 
TABLE -16 
 
S.No Cavity SIS  Hysterectomy  
1 Normal 21 21 
2 Polyp( benign) 3 3 
3 Sub mucous fibroid   4 3 
4 Intramural fibroid discretions 
cavity 
5 6 
5 Malignancy – polyp  
                   - hyperplasia 
1 
1 
1 
1 
6 Foreign body 1 1 
 
  Cavity was normal in 21(60%) cases both in SIS and hysterectomy 
specimens. 
 Diagnosis of polyps were 4(11.4%) in SIS, 3(8.5%) benign  and 
1(2.8%) suspected malignant. But in the specimen only 3 (8.5%)benign 
polyps  were identified,  the suspected malignant polyp was actually, a 
foreign body- lippes loop.  Diagnosis of sub mucous fibroids were 4(11.4%) 
by SIS but only 3(8.5%) were actually submucosal in  specimens. The other  
case of suspected malignancy with focal irregular polypoid projections 
showed  features of carcinoma  endometrium in actual specimen also. 
 
 
 
 
 
 
 
 
N
or
m
al
1
S
ub
 m
uc
ou
s 
fib
ro
id
 
3
M
al
ig
na
nc
y 
– 
po
ly
p
5
No. of patients
0
5
10
15
20
25
CORRELATION BETWEEN SIS & HYSTERECTOMY 
SPECIMENS
No. of patients
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATIONS  
TABLE -17 
 
 
S.No Complications No. of 
Patients
Percentage 
1. Post procedure pain 2 4% 
2. Others Nil - 
 
 Only 4% patients complained of abdominal pain after the procedure. 
There was no other complications.   
 
 
 
 
 
COMPARISON OF HPE AND SIS 
TABLE 18 
 
 
 
True positives True negatives  sensitivity  PPV  
13 15 15   37 
False positives False negatives specificity NPV  
22 -  42 100 
 
                  When findings of histopathologic examination of endometrium 
was taken as the confirmatory ,SIS findings had 22(44%) false positives and 
no false negatives.There were 13(26%) true positives and 15(30%) true 
negatives.Sensitivity and Negative predictive value 100% but Specificity 
and Positive predictive value were 42% and 37% respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPARISON OF   SIS FINDINGS & HYSTERECTOMY 
SPECIMENS 
TABLE 19 
 
S.N
o 
Lesion Tru
e 
+ve 
Fals
e 
+ve 
Tru
e -ve
Fals
e -ve 
Sen Spe PP
V 
NPV 
1. Polyps  3 1 31 - 100 96.8
5 
75 100 
2 Sub 
mucous 
fibroid  
3 1 31 - 100 96.8
5 
75 100 
3 I M fibroid 
distorting 
cavity 
5 - 29 1 83.3
3 
100 100 96.6
6 
4 Malignanc
y 
2 1 33 - 100 97 66.6 100 
           
 
 
                      Taking the findings of hysterectomy specimens on cut 
sections as the gold standard SIS findings were compared.There was one 
false positive (2.85%) in diagnosis each of polyp submucousal fibroid and 
malignancy.There was one(2.85%)negative in the diagnosis of intra mural 
fibroid distorting cavity.Sensitivity and negative predictive value were each 
100% for polyps,submucous fibroid and malignancy.But for intra mural 
fibroid distorting cavity sensitivity was 83.33% and negative predictive 
value was 96.66% while specificity and positive predictive value were 
100%.For polyps,submucous fibroid,malignancy,specificity and positive 
predictive value were 96.85%,96.85%,97% and  75%,75%,66.6% 
respectively. 
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DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
                        Abnormal uterine bleeding is common in the peri and post 
menopausal women. The etiology varies from simple dysfunctional uterine 
bleeding to benign lesions like polyps and malignancies.Apart from the 
clinical examination, various diagnostic modalities are available to confirm 
our diagnosis. 
 
                      In our study the efficacy of Saline infusion sonohysterography 
in diagnosing abnormal uterine bleeding and its correlation with 
histopathology of endometrium by fractional curettage and  hysterectomy 
specimens  was studied. 
 
 In our study 88% patients  belonged to 40-50 yrs .Only 12% were in 
51-55 yrs age group. In study by valenzano, Lijoi D, 2003 ,out of 73 pts, 
64% were of median age 38.9 years, 35.6% were in median age 60.5 years 
32. A few post menopausal women >50 yrs had to be  excluded  because of 
cervical stenosis which prevented  effective intrauterine catheterisation  
 
            In our study only 2% were nulli para .60% were  para2 and 
para3.Nulliparous women have 2 to 3 times relative risk of developing 
endometrial carcinoma.(Novak  et al)In women of low parity with abnormal 
uterine bleeding most common etiology is fibroid uterus. 
 
 In our study majority of patients belonged to low socio economic 
status.High prevalence of  pelvic inflammatory and lower genital tract 
lesions in this class of patients led to the exclusion of many patients from the 
study.This group of patients also have decreased awareness towards 
appropriate health care facilities and novel investigations like hysteroscopy. 
                 In our study  82 % patients  had perimenopausal  abnormal uterine 
bleeding and 18% had post menopausal bleeding. The study sample is 
similar to that of Pasrija, Trivedi and Narula 2004 whose sample had 89% 
perimenopausal and 11% post menopausal patients  .Ratio of incidence of 
perimenopausal to post menopausal abnormal uterine bleeding in GRH OP 
statistics is about 1:4. 
 
          In our study,14% were diabetic,22% had hypertension,26% had 
BMI>25.Association of diabetes, hypertension and obesity places the patient 
at high risk in the evaluation of abnormal uterine bleeding to rule out 
malignancy of the endometrium.Patients with diabetes have a relative risk of 
8 and obesity have relative risk of 10 for developing endometrial 
carcinoma.[Novak et al] 
 
  In our study, taking  more than 5 mm as the cut off value for the sum 
of anterior and posterior wall thickness, 70 % patients had endometrial  
thickening . Out of which 62% had generalised thickening  and 8% had focal 
thickening. In study by goldstein SR, Zelster, Horan, with  single layer cut 
off thickness <3 mm, 23% had generalised hyperplasia, 1% had focal 
hyperplasia.  
 
  In our study, out of 31 cases  of globally thickened endometrium 
38.7%  had proliferative endometrium , 32.2% had secretory endometrium 
and 29% had cystoglandular hyperplasia, 3.2 % had adenomatous 
hyperplasia. In goldstein’s study, 50% had proliferative endometrium 50% 
had hyperplasia 14. 
  According to Descargues , Lemercier & colleagues 2001 while 
comparing  the results of sonohysterography and histopathological  
examination, positive predictive value & negative predictive value were 83% 
and 100 % . 
 
 In our study positive predictive value was low  37% but negative 
predictive value was 100%. This may be due to interpretation errors 
associated with simple mucous hypertrophy as hyperplasia. Also patients 
with irregular  cycles, the timing of  the procedure could not be  exactly 
made at the early proliferative phase and quite a number of patients  around 
26% had secretory endometrium on the HPE.  
 
This contributes to 57% of patients with suspected hyperplasia.In few 
cases,when cavity was forcibly distended with, there was a decrease in the 
thickness of endometrium by 1-2 mm with SIS compared to TVS. 
 
              In our study clinical diagnosis of fibroids was made in 10%.This 
increased to 20% with TVS.With saline instillation,diagnosis of fibroids 
increased to 22% since a 2.5*2.5 cm submucosal fibroid came into view 
only after saline instillation. 
 
  Among findings  exclusively diagnosed by SIS, endometrial  polyps 
were found in 8.5% , sub mucous fibroids in 8.5%, intramural fibroid 
distorting cavity in  12%, malignancy  in 2.8%. In study by Pasrija, Trivedi 
S.S, Narula ML 2004, 3.4% had sub mucous fibroids, 6.8% had polyps and 
3.4% had suspected carcinoma thus almost correlating with our study. 
   In our study,the sensitivity  of SIS in comparison with hysterectomy 
specimens is 100% for polyp, sub mucous fibroids  , intramural fibroids 
distorting  cavity and  malignancy . Conventional  TVS missed,\ polyps, and  
suspected only 4% sub mucous fibroids.  
 
The  sensitivity of SIS in the study  by Valenzano, Lijoi and colleagues 
is also 100% in perimenopausal women.  In post menopausal women, the 
sensitivity of SIS was 100% for hyperplasia,93.8% for polyps but it 
decreased to 75% for submucosal fibroids. 
 
 
 Diagnosis of polyps were 8% in our study by SIS.In the actual 
specimens only 6% polyps were identified.One suspected malignant polyp 
was a foreign body,forgotten lippes loop partially embedded in the 
myometrium.Diagnosis of submucous fibroids were 8% by SIS, but only 6% 
were submucosal in actual specimen.An intramural fibroid distorting the 
cavity was mistaken for submucosal fibroid in SIS. 
 
  In our study,the specificity of SIS for diagnosing polyps, sub mucous  
fibroids, intramural fibroids distorting cavity  and malignancy are 96.85%, 
96.6%, 97% respectively. According to  Pasrija and others , specificity  was  
88.5%  on the whole.( less than our study) . 
 
 Negative predictive value overall is 100% in our study. Positive 
predictive value for polyps, sub mucous fibroids, intramural fibroids 
distorting cavity  and malignancy are 75%, 75%,83.3, 66.6%  respectively. 
 In Deuholm, Forman & colleagues 2001 study, positive predictive 
values were 98% and negative predictive values were 85%  thus correlating 
with our study. 
 
 According to Nanda. S, Chadha N & colleagues, in whose study  
hysterectomy findings were kept  as the gold standard,  the sensitivity & 
specificity were 100% for polyps , 97.8%  comparable to our study. For 
submucous  fibroids, sensitivity was 89.5%, specificity 100%where as our 
study had 100% sensitivity. 
 
 Detection of focal hyperplasia is significant  as 75 % with focal 
hyperplasia had abnormal histopathology of endometrium requiring surgical 
interventions. 
 
In our study only 2% patients complained of abdominal pain after the 
procedure. There was no severe complications as endometritis. This is in par 
with Bonnamy L, Marret H and others, in whose study out of 81% patients, 
the incidence of pelvic pain was 1.2% and endometritis 1.2%.    
 
 
 
 
 
 
 
 
  
 
 
 
 
 
SUMMARY 
 
 
 
 
  SUMMARY 
 
1. Fifty consecutive patients in peri & post menopausal  age group  with 
abnormal uterine bleeding  attending  GRH gynaecology  OP, were 
taken up for study. 
 
2. Majority belonged to the age group of 40-50 yrs (80%), 12% were in 
51-55 yrs group. 
 
3. Parity of 2 and 3 were maximum at 60%,followed by parity of 4 in 
32%.only one patient out of 50 was a nullipara. 
 
4. Majority (80%)belonged to low socio economic status. 
 
5. Perimenopausal women constituted 82% and post menopausal women 
18%. 
 
6. Clinical presentation of abnormal uterine bleeding were: menorrhagia 
and polymenorrhagia in 75%,polymenorrhea in 9.75% and 
menometrorrhagia in 14.6% 
 
7. Post menopausal women with bleeding per vaginum reported early 
within a month of onset of symptoms whereas perimenopausal 
patients reported late within a year of onset of symptoms. 
 
 
8. High risk factors for endometrial cancer existed ithe form of diabetes 
in 14%,hypertension in22%,obesity in 24%.Overt anemia was present 
in 26% of women.  
 
9.  Associated clinical gynaecological  conditions were  present in 22% 
patients, out of which the commonest was fibroid in 46%. 
 
10. Associated findings in TVS & SIS were:  fibroids in 20% 
adenomyosis   in 14%, hydrosalphinx in 2%, ovarian cyst in 4%. 
 
11. Generalised endometrial thickening was diagnosed in 62% and focal  
endometrial thickeing in 8 % in SIS  
 
12. Out of  those with generalised thickening 32.25% had proliferative 
endometrium, 35.48% had secretory endometrium, 29% had cysto 
glandular hyperplasia 3.2% had simple adenomatous hyperplasia. 
 
13. Out of  those with focal hyperplasia ,25% had atypical adenomatous 
hyperplasia, 25% had disorderly proliferlative endometrium, 25% 
cysto glandular hyperplasia, 25 % adenocarcinoma. 
 
14. Sensitivity and negative predictive value of SIS with  HPE is 100% 
but specificity & positive predictive value are low 42% &37% 
respectively  
 
15. In SIS endometrial polyps were diagnosed is 8% ,submucous fibroids 
in 8 % focal thickening of endometrium in 8% , intramural fibroids  
distorting cavity in 10% suspected malignancy 4%. 
 
16. (one)2% intramural fibroid was mistaken for a sub mucous fibroid in 
SIS,(one)2% polyp (malignant) by SIS actually turned out to be 
forgotten lippes loop ( in hysterectomy specimen). 
 
17. Sensitivity, negative predictive value of SIS for diagnosis of polyps, 
submucous fibroids and  malignancy was 100%.The sensitivity and 
negative predictive value for diagnosing intra mural fibroids distorting 
cavity was 83.33% and 96.66%. 
 
18. Specificity for polyps, sub mucous fibroids both  96.5% each, for 
intramural fibroids distorting cavity 100% and malignancy 97% .Positive 
predictive value for diagnosing malignancy was low 66.6%, for fibroids 
distorting cavity 100%, for both sub mucous fibroids & polyps each 75%. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
  
CONCLUSION 
 
Saline infusion sonohysterography is an ideal,cost effective,minimally 
invasive  investigation to be done as the first step in the evaluation of 
abnormal uterine bleeding in perimenopausal and post menopausal patients.  
        
This will alone be sufficient in most patients except very few who will 
require subsequent confirmation with  sophisticated investigation like 
hysteroscopy.  
 
SIS has an overall sensitivity and negative predictive value of 100% 
but positive predictive value and specificity  are less. But it is still high  
for detecting focal endometrial  abnormalities. 
 
 Combined with histopathology, specificity and positive 
predictive value can be increased further, false positives can be reduced. 
  
The findings in SIS correlated almost in 76% of cases with 
histopathology of endometrium in fractional curettage and 95%  with 
hysterectomy specimens.  
  
Accordingly, the best  suited management  can be chosen  for the 
individual patient among the varied options of medical, minimally 
invasive or surgical procedures. 
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PROFORMA 
 
 
 
 
 
 
 
 
NAME: 
 
AGE: 
 
UNIT:                      Date of admission:                 Date of SIS:                Address: 
 
Socio economic status: 
 
IP NUMBER: 
 
MARITAL STATUS: 
 
PARITY: 
 
MENARCHE: 
 
DURATION OF CYCLES: 
                                              (before  the presenting complaint) 
DURATION OF FLOW: 
                                               Perimenopausal                                         Postmenopausal 
 
COMPLAINTS:                                
 
Duration of cycles:                                                                              Menopause 
Duration of flow:                                                                                 Duration of bleeding; 
H/O amenorrhea before bleeding:yes/no;if yes,duration-                    h/o passing clots: 
Regularity of cycles:                                                                            Discharge PV: 
Number of diapers used/day                                                                Abdominal pain: 
H/O passing clots: 
H/O dysmenorrhea : yes/no; if yes,spasmodic/congestive 
Last menstrual period: 
Intermenstrual bleeding: 
Postcoital bleeding: 
 
TYPE OF ABNORMAL UTERINE BLEEDING: 
 
Other bleeding tendencies: 
H/O abnormal discharge pv 
H/O thyroid dysfunction:                          weight gain: 
H/O IUCD inserttion/OCP intake: 
H/O abortion/recent child birth: 
H/O intake of sex hormones: 
H/O sterilization: 
 
 
 
GENERAL EXAMINATION: 
Height:                        Weight:                                             Body mass index: 
Anaemia:yes/no 
Edemalegs:yes/no 
Others: 
Breast: 
Thyroid: 
 
VITAL SIGNS:               pulse:                       blood pressure: 
 
EXAMINATION OF ABDOMEN: 
 
 
 
 
 
SPECULUM EXAMINATION: 
 
 
 
BIMANUAL EXAMINATION: 
 
 
 
EVALUATION:    haemoglobin%:      blood grouping:         CT:         BT:         CRT: 
 
 
 
 
 
TRANS VAGINAL SONOGRAPHY: 
 
 
 
 
SALINE INFUSION SONOHYSTEROGRAPHY: 
             
       Endometrial thickness: 
       Endometrial hyperplasia:  localized/generalized 
       Polyps 
       Fibroids 
       Intra uterine adhesions: 
       Other significant findings: 
 
histapathology if available: 
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CLINICAL 
DIAGNOSIS 
TRANSVAGINAL 
SONOGRAPHY 
SALINE INFUSION 
SONOHYSTEROGRAP
  
  
    
ASSOCIATE
D 
FINDINGS 
                       CAVIT
  
  
     
THICKNES
S 
GH FH PO
LY
P 
1 Meena  43 357285 P3 IV PEMB 1Om Ane Cervical polyp 2  THIN    
2 Lilly pushpum 55 380637 P4 
IV PEMB 
2y HT DUB 12  
6+6 √   
3 Tamilselvi 40 380500 P1 
III PEMB 
2m OW 
R ADNEXAL 
MASS 5 
Rhydrosalpi
nx 
2+2    
4 Kasthuri 48 380496 P5 
V PEMB 
1y -  8  
4+4 √   
5 Kuruvamal 40 380494 P4 
V PEMB 
1y -  10 
ADENOMYO
SIS 
5+5 √   
6
Thavamani 43 380988 P2 
III PEMB 
3m -  24  
7+7 √  1.
2x
1.
8C
M 
7 Meenakshi 49 381002 P2 
V PEMB 
6 M OW  8 I.M myoma 
4+4 √   
8 Mariamal 43 343695 P3 
V PEMB 
2 Y 
OW ANE HT 
DM  18  
8+8 √   
9
222
Irulayee 45 396161 P3 
V PEMB 
1.5 Y - cervicalpolyp 7 
adenomyosi
s 
3+3 √   
10 Panjavarnam 45 387209 P3 
V PEMB 
1 Y -  6  
3+3 √   
11 Chinathai 55 387331 P2 
V PMB 
6 M Ane  18  
8+9  √  
12 Velathai 47 387332 P7 
IV PEMB 
1 Y 
Ow 
Ane fibroid 4 I.M myoma 
2+2    
13 Guruvamal 55 381091 P5 V PMB 2 M OB  26  2+2    
14 Kaliammal 50 388350 P6 IV PEMB 10 M HT  14  7+7    
15 Mari 45 389045 P3 
V PEMB 
8 M DM  6 
adenomyosi
s 
3+3    
16 Rathi 40 389040 P3 
V PEMB 
6 M   12 
adenomyosi
s 
6+6    
17
Rahmath 
Beevi 42 390755 P3 
V PEMB 
1 Y OW  4 I.M myoma 
2+2    
18 Pappa 45 406031 P2 
V PEMB 
7 M -  12  
6+6 √   
19 Saratha 45 405606 P5 
V PEMB 
6 M Ane 
L adnexal 
mass 7 
Ovarian 
cyst-func 
4.5+4.5 √   
20 Saroja 42 406835 P3 V PEMB 2 Y -  4  2+2    
21 Soundammal 43 415209 P2 
V PEMB 
1 Y OW  12  
6+6 √   
22 Veni 45 415402 P2 V PEMB 4 M DM  4 I.M myoma 2+2    
23 Jeyalakshmi 40 424175 P2 
V PEMB 
6 M -  6 
I.M 
myoma+ 
adenomyosi
s 
3+3    
24 Sundari 42 430956 P2 
V PEMB 
7 M DM  16  
7+9  √  
25 Vijayalakshmi 40 423796 P4 
V PEMB 
2 Y OW  8 
adenomyosi
s 
4+4 √   
26 Mariammal 54 446327 P4 
V PEMB 
2 Y 
OW 
HT  8 
adenomyosi
s 
4+4 √   
27 Amirtham 55 446465 P5 
V PMB 
5 D 
OW 
HT  8  
4+4    
28 Irulayee 47 446770 P4 
V PEMB 
6 M OW  25  
11+ 14  √  
29 Lakshmi 50 453682 P3 
V PEMB 
8 M - 
L adnexal 
mass 24 
L ovarian 
cyst-func 
11+ 13  √  
30 Malarkodi 48 454071 P2 
V PEMB 
6 M -  10  
4+4 √   
31 Dhanalakshmi 49 497558 P2 
V PEMB 
4 Y OW,Ane,HT  10  
5+5 √   
32 Muniammal 45 443582 P3 
V PEMB 
3 M 
DM 
Ane  10  
5+5 √   
33 Rajeshwari 40 436123 P3 IV PEMB 2 M Ane  4  2+ 2    
34 Palaniammal 40 454709 P2 V PEMB 1Y -  6  3+3    
35 Pandiamal 50 455546 P2 III PMB 2 W HT Cervical polyp 2  thin    
36 Chandra 49 455557 P4 V PMB 2 D -  2  thin    
37 Pushpam 50 455099 P3 
V 
PEMB I Y 
OW 
HT  23  
10+ 10 √  1*
1 
38 Ayammal 46 447370 P2 V PMB 2 D DM  4  2+2    
39 Chellathai 46 447364 P3 
V 
PEMB 8 M - Fibroid 6 
Sub 
serous+I.M 
3+3 √   
40 Nagammal 52 470244 P1 
V 
PEMB 6 M HT  18  
9+9 √   
41 Pushpavalli 50 470247 P7 V PMB 10 D   2  thin    
42 Panjavarnam 45 408370 P2 
V 
PEMB 2 Y DM HT Fibroid 6 I.M myoma 
3+3 √   
43 Chitamal 47 473063 P5 V PEMB 4 Y Ane  18  9+9    
44 Mookamal 50 473061 P2 V PEMB 6 M HT    3+3    
45 Malayamal 50 473068 P4 V PMB 1 W -  4  2+2    
46 Akkamal 50 473069 P3 
V 
PMB 3 D -  8  
4+4 √   
47 Sundaramal 46 473979 P3 IV PEMB 2 Y Ane Fibroid 6 I.M myoma 
3+3 √   
48 Sangamal 46 473978 PO V PEMB 6 M - Fibroid 3 Multiple I.M 
1.5+ 1.5    
myoma 
49 Alagu pillai 45 47399 P1 V PEMB 3M Ane  2  thin    
50 Andichi 40 473474 P4 
V 
PEMB 1Y Ane  18  
9+9 √   
 
 
 
